Retrospective study of the predictors of mortality and radiographic deterioration in 782 patients with nodular/bronchiectatic Mycobacterium avium complex lung disease

BMJ Open

Volumn 5, Issue 8, 2015, Pages

  Gochi, Mina ^a   Takayanagi, Noboru ^a   Kanauchi, Tetsu ^a   Ishiguro, Takashi ^a   Yanagisawa, Tsutomu ^a   Sugita, Yutaka ^a  

^a Department of Respiratory Medicine Saitama Cardiovascular and Respiratory Center ^*  (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CLARITHROMYCIN; ETHAMBUTOL; HEMOGLOBIN; ISONIAZID; QUINOLONE DERIVATIVE; RIFAMPICIN; STREPTOMYCIN; ANTIINFECTIVE AGENT;

AGE; AGED; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BODY MASS; CAUSE OF DEATH; COHORT ANALYSIS; DETERIORATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOALBUMINEMIA; INFECTION RISK; JAPAN; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; NODULAR BRONCHIECTATIC MYCOBACTERIUM AVIUM COMPLEX LUNG DISEASE; OUTCOME ASSESSMENT; PROGNOSTIC ASSESSMENT; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; RISK FACTOR; THORAX RADIOGRAPHY; BRONCHIECTASIS; CLASSIFICATION; COMPLICATION; DISEASE COURSE; EPIDEMIOLOGY; GENETICS; KAPLAN MEIER METHOD; LUNG; LUNG DISEASE; MICROBIOLOGY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; MYCOBACTERIUM AVIUM COMPLEX; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SERODIAGNOSIS; SPUTUM;

AGED; ANTI-BACTERIAL AGENTS; BRONCHIECTASIS; CAUSE OF DEATH; DISEASE PROGRESSION; FEMALE; HIV SERONEGATIVITY; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; LUNG; LUNG DISEASES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SPUTUM;

EID: 84941564215     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-008058     Document Type: Article

References (35)

1. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175:367-416.
2. Andréjak C, Thomsen VØ, Johansen LS, et al. Nontuberculous pulmonary mycobacteriosis in Denmark: incidence and prognostic factors. Am J Respir Crit Care Med 2010;181:514-21.
3. Prevots DR, Shaw PA, Strickland D, et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med 2010;182:970-6.
4. Winthrop KL, McNelley E, Kendall B, et al. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med 2010;182:977-82.
5. Cassidy PM, Hedberg K, Saulson A, et al. Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin Infect Dis 2009;49:e124-9.
6. Reich JM, Johnson RE. Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern. The Lady Windermere syndrome. Chest 1992;101:1605-9.
7. Prince DS, Peterson DD, Steiner RM, et al. Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 1989;321:863-8.
8. Hunter AM, Campbell IA, Jenkins PA, et al. Treatment of pulmonary infections caused by mycobacteria of the Mycobacterium avium-intracellulare complex. Thorax 1981;36:326-9.
9. Davidson PT, Khanijo V, Goble M, et al. Treatment of disease due to Mycobacterium intracellulare. Rev Infect Dis 1981;3:1052-9.
10. Ahn CH, Ahn SS, Anderson RA, et al. A four-drug regimen for initial treatment of cavitary disease caused by Mycobacterium avium complex. Am Rev Respir Dis 1986;134:438-41.
11. Etzkorn ET, Aldarond S, McAllister CK, et al. Medical therapy of Mycobacterium avium-intracellulare pulmonary disease. Am Rev Respir Dis 1986;134:442-5.
12. Dutt AK, Stead WW. Long-term results of medical treatment in Mycobacterium intracellulare infection. Am J Med 1979;67:449-53.
13. Griffith DE, Brown-Elliott BA, Langsjoen B, et al. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2006;174:928-34.
14. Lam PK, Griffith DE, Aksamit RA, et al. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2006;173:1283-9.
15. Tanaka E, Kimoto T, Tsuyugushi K, et al. Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease. Am J Respir Crit Care Med 1999;160:866-72.
16. Wallace RJ Jr, Brown BA, Griffith DE, et al. Clarithromycin regimens for pulmonary Mycobacterium avium complex: The first 50 patients. Am J Respir Crit Care Med 1996;153:1766-72.
17. Dautzenberg B, Piperno D, Diot P, et al. Clarithromycin in the treatment of Mycobacterium avium lung infections in patients without AIDS. Chest 1995;107:1035-40.
18. Field SK, Cowie RL. Treatment of Mycobacterium avium-intracellulare complex lung disease with a macrolide, ethambutol, and clofazimine. Chest 2003;124:1482-6.
19. Hasegawa N, Nishimura T, Ohtani S, et al. Therapeutic effect of various initial combinations of chemotherapy including clarithromycin against Mycobacterium avium complex pulmonary disease. Chest 2009;136:1569-75.
20. Jenkins PA, Campbell IA, Banks J, et al. Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung disease and assessment of Mycobacterium vaccae immunotherapy. Thorax 2008;63:627-34.
21. [No authors listed]. Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow up of patients receiving standardised treatment. Int J Tuberc Lung Dis 2002;6:628-34.
22. Adjemian J, Olivier KN, Seitz AE, et al. Prevalence of nontuberculous Mycobacterial lung disease in U. S. Medicare beneficiaries. Am J Respir Crit Care Med 2012;185:881-6.
23. Morimoto K, Iwai K, Uchimura K, et al. A steady increase in nontuberculous mycobacteriosis mortality and estimated prevalence in Japan. Ann Am Thorac Soc 2014;11:1-8.
24. Hayashi M, Takayanagi N, Kanauchi T, et al. Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2012;185:575-83.
25. Xu HB, Jiang RH, Li L. Treatment outcomes for Mycobacterium avium complex: a systematic review and meta-analysis. Eur J Clin Microbiol Infect Dis 2014;33:347-58.
26. Kitada S, Uenami T, Yoshimura K, et al. Long-term radiographic outcome of nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Int J Tuberc Lung Dis 2012;16:660-4.
27. Wallace RJ Jr, Brown-Elliott BA, McNulty S, et al. Macrolide/azalide therapy for nodular/bronchiectatic Mycobacterium avium complex lung disease. Chest 2014;146:276-82.
28. Ito Y, Hirai T, Maekawa K, et al. Predictors of 5-year mortality in pulmonary Mycobacterium avium-intracellulare complex disease. Int J Tuberc Lung Dis 2012;16:408-14.
29. Marras TK, Prevots DR, Jamieson FB, et al., Pulmonary MAC Outcomes Group. Opinions differ by expertise in Mycobacterium avium complex disease. Ann Am Thorac Soc 2014;11:17-22.
30. Leber A, Marras TK. The cost of medical management of pulmonary nontuberculous mycobacterial disease in Ontario, Canada. Eur Respir J 2011;37:1158-65.
31. Koh WJ, Jeong BH, Jeon K, et al. Clinical significance of the differentiation between Mycobacterium avium and Mycobacterium intracellulare in Mycobacterium avium complex lung disease. Chest 2012;142:1482-8.
32. Lee G, Kim HS, Lee KS, et al. Serial CT findings of nodular bronchiectatic Mycobacterium avium complex pulmonary disease with antibiotic treatment. Am J Roentgenol 2013;201:764-72.
33. Kim SJ, Park J, Lee H, et al. Risk factors for deterioration of nodular bronchiectatic Mycobacterium avium complex lung disease. Int J Tuberc Lung Dis 2002;18:730-6.
34. Yamazaki Y, Kubo K, Takamizawa A, et al. Markers indicating deterioration of pulmonary Mycobacterium avium-intracellulare infection. Am J Respir Crit Care Med 1999;160:1851-5.
35. Kuroishi S, Nakamura Y, Hayakawa H, et al. Mycobacterium avium complex disease: prognostic implication of high-resolution computed tomography findings. Eur Respir J 2008;32:147-52.